anyone's doing RNA-seq with paired-end reads now? how to use pairing information is a challenge. any good ideas?
Unconfigured Ad
Collapse
X
-
Yes. We've done paired end RNAseq - partly because of mixed sample type (some DNAseq etc) flow cells.
The paired end info is useful for novel gene expression and splice junction discovery.
For simple RPKM etc we just treated each read as single end and aligned to genome+splice junctions seperately - this is likely to be suboptimal although easy approach. I'd be very interested in people's comments...
david
-
-
Rna-pet
Paired-end ditags (PET) is an interesting strategy. It is very economical way of finding splice junction variants. Of course it doesn't offer the same resolution as full paired end RNA-Seq. I believe the team at GIS have migrated to Illumina and SOLiD in particular for RNA-PET now.
Comment
-
-
Hi all, We have had success with PE RNAseq (illumina).
Some of the main pitfalls that we found:
-when you make your cDNA, if you use random hexamers (best results for us), your first strand synthesis reaction will tend to produce sequences that start/end in GC rich sequences. We have found that these tend to be non-accurate annealling products, and you can improve your mapping efficiency by stripping the first/last few bases.
- TopHAT (see bowtie/ben langmeads posts) has also been very useful (and extremely fast for mapping!!
- Creating 'spliced' reference genomes is very useful for retaining the benefits of PE mapping, without having to introduce huge 'insert' sizes...
- Avoid PET tags - the extra ligation steps, if you are not careful, can introduce a high percentage of 'false' splice events... With the illumina PE strategy there is no need for this...
Has anyone had any luck with barcoding RNAseq samples?
Ieuan
Comment
-
-
Originally posted by ieuanclay View PostHi all, We have had success with PE RNAseq (illumina).
Some of the main pitfalls that we found:
-when you make your cDNA, if you use random hexamers (best results for us), your first strand synthesis reaction will tend to produce sequences that start/end in GC rich sequences. We have found that these tend to be non-accurate annealling products, and you can improve your mapping efficiency by stripping the first/last few bases.
- TopHAT (see bowtie/ben langmeads posts) has also been very useful (and extremely fast for mapping!!
- Creating 'spliced' reference genomes is very useful for retaining the benefits of PE mapping, without having to introduce huge 'insert' sizes...
- Avoid PET tags - the extra ligation steps, if you are not careful, can introduce a high percentage of 'false' splice events... With the illumina PE strategy there is no need for this...
Has anyone had any luck with barcoding RNAseq samples?
Ieuan
Hi Ieuan,
It is interesting to see PE RNAseq.
I still ahve some doubts regarding mapping PE reads. Because ELAND can support eland_rna analysis for SR(single read) only.
Any tool to map tags with splice juction or can you please explain about the mapping part of PE RNA seq tags?
Thanks.
Comment
-
-
Check the forums here for TopHat if you want to know about mapping RNAseq!
The actual way that you map is very dependent on the source of your RNA, so i would need to know more about your experiments! My main experience is with nascent RNA, so we PE map againstt a genomic reference. Spliced RNA can be mapped against spliced genomes (again see TopHat). Or a combination of both can be used, i.e. mapping against the genomic reference using a sensible PE insert limit, to find nascent RNA, then mapping the reads that don't map to the reference genome against a spliced genome. This way you can flag potentially spliced and unspliced transcripts.
There really are too many ways of proceeding, you just have to pick a processing pipeline that makes sense for your material/experiment and that you can justify when it comes to publishing.
Hope this helps!?
Comment
-
Latest Articles
Collapse
-
by mylaserKheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
This guide explains everything you need to know about...-
Channel: Articles
Yesterday, 01:13 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
11 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
||
|
Started by SEQadmin2, 07-07-2026, 11:05 AM
|
0 responses
26 views
0 reactions
|
Last Post
by SEQadmin2
07-07-2026, 11:05 AM
|
||
|
Started by SEQadmin2, 07-02-2026, 11:08 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
07-02-2026, 11:08 AM
|
Comment